Dual destructive and protective roles of adaptive immunity in neurodegenerative disorders

被引:68
作者
Anderson K.M. [1 ]
Olson K.E. [1 ]
Estes K.A. [1 ]
Flanagan K. [2 ]
Gendelman H.E. [1 ]
Mosley R.L. [1 ]
机构
[1] Department of Pharmacology and Experimental Neuroscience, Center for Neurodegenerative Disorders, The University of Nebraska Medical Center, Omaha, 68198, NE
[2] Prothena Biosciences, Inc., 650 Gateway Boulevard, South San Francisco, 94080, CA
基金
美国国家卫生研究院;
关键词
Effector T cell; MCAM; Migration; MPTP; Neurodegeneration; Neuroinflammation; Neuroprotection; Regulatory T cell;
D O I
10.1186/2047-9158-3-25
中图分类号
学科分类号
摘要
Inappropriate T cell responses in the central nervous system (CNS) affect the pathogenesis of a broad range of neuroinflammatory and neurodegenerative disorders that include, but are not limited to, multiple sclerosis, amyotrophic lateral sclerosis, Alzheimer's disease and Parkinson's disease. On the one hand immune responses can exacerbate neurotoxic responses. while on the other hand, they can lead to neuroprotective outcomes. The temporal and spatial mechanisms by which these immune responses occur and are regulated in the setting of active disease have gained significant recent attention. Spatially, immune responses that affect neurodegeneration may occur within or outside the CNS. Migration of antigen-specific CD4+ T cells from the periphery to the CNS and consequent immune cell interactions with resident glial cells affect neuroinflammation and neuronal survival. The destructive or protective mechanisms of these interactions are linked to the relative numerical and functional dominance of effector or regulatory T cells. Temporally, immune responses at disease onset or during progression may exhibit a differential balance of immune responses in the periphery and within the CNS. Immune responses with predominate T cell subtypes may differentially manifest migratory, regulatory and effector functions when triggered by endogenous misfolded and aggregated proteins and cell-specific stimuli. The final result is altered glial and neuronal behaviors that influence the disease course. Thus, discovery of neurodestructive and neuroprotective immune mechanisms will permit potential new therapeutic pathways that affect neuronal survival and slow disease progression. © 2014 Anderson et al.
引用
收藏
相关论文
共 154 条
[1]  
Amor S., Peferoen L.A., Vogel D.Y., Breur M., van der Valk P., Baker D., van Noort J.M., Inflammation in neurodegenerative diseases-an update, Immunology, 142, pp. 151-166, (2014)
[2]  
Mosley R.L., Hutter-Saunders J.A., Stone D.K., Gendelman H.E., Inflammation and adaptive immunity in Parkinson's disease, Cold Spring Harb Perspect Med, 2, (2012)
[3]  
Pachter J.S., de Vries H.E., Fabry Z., The blood-brain barrier and its role in immune privilege in the central nervous system, J Neuropathol Exp Neurol, 62, pp. 593-604, (2003)
[4]  
Carson M.J., Doose J.M., Melchior B., Schmid C.D., Ploix C.C., CNS immune privilege: hiding in plain sight, Immunol Rev, 213, pp. 48-65, (2006)
[5]  
Ziv Y., Ron N., Butovsky O., Landa G., Sudai E., Greenberg N., Cohen H., Kipnis J., Schwartz M., Immune cells contribute to the maintenance of neurogenesis and spatial learning abilities in adulthood, Nat Neurosci, 9, pp. 268-275, (2006)
[6]  
Engelhardt B., T cell migration into the central nervous system during health and diseas: Different molecular keys allow access to different central nervous system compartments, Clin Exp Neuroimmunol, 1, pp. 79-93, (2010)
[7]  
Sobel R.A., Mitchell M.E., Fondren G., Intercellular adhesion molecule-1 (ICAM-1) in cellular immune reactions in the human central nervous system, Am J Pathol, 136, pp. 1309-1316, (1990)
[8]  
Cannella B., Raine C.S., The adhesion molecule and cytokine profile of multiple sclerosis lesions, Ann Neurol, 37, pp. 424-435, (1995)
[9]  
Bahbouhi B., Berthelot L., Pettre S., Michel L., Wiertlewski S., Weksler B., Romero I.A., Miller F., Couraud P.O., Brouard S., Laplaud D.A., Soulillou J.P., Peripheral blood CD4+ T lymphocytes from multiple sclerosis patients are characterized by higher PSGL-1 expression and transmigration capacity across a human blood-brain barrier-derived endothelial cell line, J Leukoc Biol, 86, pp. 1049-1063, (2009)
[10]  
Kim S., Cho S.H., Kim K.Y., Shin K.Y., Kim H.S., Park C.H., Chang K.A., Lee S.H., Cho D., Suh Y.H., Alpha-synuclein induces migration of BV-2 microglial cells by up-regulation of CD44 and MT1-MMP, J Neurochem, 109, pp. 1483-1496, (2009)